Who Discovered The Chemical Structure Of Sildenafil In ZHEWITRA 10 MG?
The chemical structure of Sildenafil, the active ingredient in medications like Zhewitra 10 mg, was discovered by scientists working at the pharmaceutical company Pfizer in the late 1980s and early 1990s. The discovery was part of Pfizer’s research to develop treatments for cardiovascular diseases, specifically angina (chest pain).
Discovery Background:
A team of chemists and pharmacologists, including Dr. Nicholas Terrett and Dr. Peter Dunn, played key roles in identifying Sildenafil’s structure and its potential as a phosphodiesterase type 5 (PDE5) inhibitor. Although initially aimed at treating heart-related conditions, clinical trials revealed Sildenafil’s unexpected effect on improving erectile function.
This led Pfizer to repurpose the drug, resulting in the development of what became the world’s first oral treatment for erectile dysfunction, marketed as Viagra.
Zhewitra 10 mg Context:
Zhewitra 10 contains Sildenafil citrate, the same chemical compound discovered by Pfizer. It is a generic or branded formulation that uses this well-established molecule to help treat erectile dysfunction effectively.
The chemical structure of Sildenafil, used in Zhewitra 10 mg, was discovered by Pfizer scientists in the early 1990s. Their work transformed Sildenafil from a cardiovascular drug candidate into a revolutionary treatment for erectile dysfunction.  |